Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Conditions
- Adenocarcinoma of the Lung
Interventions
- DRUG: Camrelizumab
- DRUG: Albumin Paclitacxel
- DRUG: Apatinib
Sponsor
Hunan Cancer Hospital
Collaborators